Global swine vaccines market was valued at 506 Million US$ in 2018 and is projected to reach 676 Million US$ by 2024
Swine vaccine is a kind of vaccines used for swine influenza. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. It mainly has two types: SlV inactivated vaccines and SlV subunit vaccines.
Global swine vaccines market
was valued at 506 Million US$ in 2018 and is projected to reach 676 Million US$ by 2024, at a CAGR of 4.96% during the forecast period
The global animal vaccines market is poised to reach $7,197.9 Million by 2020 from $5,507.3 Million in 2015, at a CAGR of 5.5% from 2015 to 2020.
Growth of the veterinary vaccines market is propelled by growing prevalence of animal diseases; rising incidences of zoonotic diseases in humans; increasing investments by various government agencies, animal associations, and leading players; continuous innovations and introduction of new veterinary vaccines. Furthermore, technological innovations like DNA vaccines, growing awareness of animal health in emerging economies, increasing investment opportunities in emerging and immature markets are also the factors driving the market growth. However, rising maintenance costs for storage of vaccines, increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders, persistent economic slowdown are key factors limiting the growth of this market.
Key players in global swine vaccine market include: MSD Animal Health, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Bioveta, Chopper Biology, Tecon, Zoetis, Ceva, WINSUN, Hipra, Ringpu Biology, ChengDu Tecbond, DHN etc.